BiOZEEN, founded in 2005, is a pioneering company in the biopharmaceutical industry, providing advanced automated bioprocess technologies for the manufacturing of vaccines and biologicals. The company's expertise in Bioprocess Engineering, Plant Automation, and Fabrication Technologies enables them to deliver customised bioprocess hardware and automation infrastructure for enhanced productivity. With a global reach across Europe, Asia, Americas and Oceania, BiOZEEN partners with pharmaceutical companies to provide result-driven production infrastructure. The company's commitment to excellence and regulatory compliance is evident through their product portfolio which includes Bioprocess Equipment such as Fermentors and Bioreactors. Additionally, their Bio-Pilot Lab and Training infrastructure emphasizes the importance of incorporating high-level quality standards into the biopharmaceutical industrial scenario. BiOZEEN's value-added integration services philosophy, which integrates process, engineering, automation, and compliance expertise, supports each phase of the project lifecycle from conceptualization to commissioning in the Pharmaceutical & Biopharmaceutical facility. With a strong focus on saving lives, BiOZEEN's award-winning processes and dedication to training the industry on implications rather than just regulations sets them apart in the biopharmaceutical manufacturing sector.
There is no investment information
No recent news or press coverage available for BiOZEEN.